CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
April 26, 2018, Oakland, CA – It’s not often you get invited to a meeting of some of the leading scientists, ethicists, philosophers and faith leaders in the world so when the call comes in it’s an easy one to answer. Particularly when the call is from the Vatican.
Maria T. Millan, MD, President and CEO of the California Institute for Regenerative Medicine (CIRM), will be part of a panel discussion at the Fourth International Vatican Conference at Vatican City, Rome. The conference, titled: Unite To Cure: How Science, Technology and 21st Century Medicine Will Impact Culture and Society, runs from April 26-28 in Rome.
“It is a tremendous honor to be part of this historic event,” says Dr. Millan. “CIRM funds the science and development of transformative cell and gene therapies for patients with unmet medical needs so it will be important to be part of the global conversation during such a propitious time in the history of medicine.”
“We’re thrilled to bring together the world’s best scientists, doctors, ethicists and leaders of faith, business, government and philanthropy to this extraordinary global event at The Vatican,” says Dr. Robin Smith, President of The Cura Foundation, the event organizer in partnership with the Vatican. “It’s a Davos for health care, and over the course of three days we will rally the world around a very simple idea — that tomorrow’s cures are just around the corner, and by uniting together and understanding the challenges that lie ahead, we can speed the delivery of cures and foster great hope for patients all over the world suffering from deadly diseases and dangerous medical conditions.”
Dr. Millan will be part of a panel discussion titled, Public Private Partnerships to Accelerate Discoveries. The panel will be moderated by award-winning medical journalist Max Gomez, PhD., and will include David Mazzo, PhD CEO of Caladrius Biosciences, and David Pearce, PhD, the Executive VP for Research at Sanford Health.
The topic for this panel is particularly well suited for CIRM, an agency that is devoted to accelerating stem cell treatments to patients with unmet medical needs. CIRM has funded over 800 projects and over 45 novel stem cell and regenerative medicine clinical trials. It delivers a predictable and expedited funding mechanism, an active partnership and advisory role, strategic infrastructure, involvement of key opinion leaders and patient representatives and an industry alliance program, all to increase the chances of success for its programs and for the patients who would benefit.
To learn more about Unite To Cure: The Fourth International Vatican Conference, please visit: http://vaticanconference2018.com. Or, you can follow the event on Twitter @CuraFdn and on Facebook at
facebook.com/TheCuraFoundation, and join the conversation with #UnitetoCure.
| About CIRM |
| At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed in that mission.
To meet this challenge, our team of highly trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell technologies. With $3 billion in funding and approximately 300 active stem cell programs in our portfolio, CIRM is the world’s largest institution dedicated to helping people by bringing the future of cellular medicine closer to reality. For more information go to www.cirm.ca.gov The Cura Foundation leads a major global health movement, with the passionate purpose to improve human health. Cura unites public and private sectors, partnering with doctors, patients, business leaders, philanthropists and thought leaders to collaborate and create breakthroughs around the world. The foundation drives change by raising awareness of scientific advancements in genomics, emerging technologies and big data to usher in the future of medicine. Cura helps people live longer, better lives free from suffering. The Cura Foundation is a nonsectarian, nonpartisan, public and tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. For more information, please visit: https://thecurafoundation.org |
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
April 26, 2018, Oakland, CA – It’s not often you get invited to a meeting of some of the leading scientists, ethicists, philosophers and faith leaders in the world so when the call comes in it’s an easy one to answer. Particularly when the call is from the Vatican.
Maria T. Millan, MD, President and CEO of the California Institute for Regenerative Medicine (CIRM), will be part of a panel discussion at the Fourth International Vatican Conference at Vatican City, Rome. The conference, titled: Unite To Cure: How Science, Technology and 21st Century Medicine Will Impact Culture and Society, runs from April 26-28 in Rome.
“It is a tremendous honor to be part of this historic event,” says Dr. Millan. “CIRM funds the science and development of transformative cell and gene therapies for patients with unmet medical needs so it will be important to be part of the global conversation during such a propitious time in the history of medicine.”
“We’re thrilled to bring together the world’s best scientists, doctors, ethicists and leaders of faith, business, government and philanthropy to this extraordinary global event at The Vatican,” says Dr. Robin Smith, President of The Cura Foundation, the event organizer in partnership with the Vatican. “It’s a Davos for health care, and over the course of three days we will rally the world around a very simple idea — that tomorrow’s cures are just around the corner, and by uniting together and understanding the challenges that lie ahead, we can speed the delivery of cures and foster great hope for patients all over the world suffering from deadly diseases and dangerous medical conditions.”
Dr. Millan will be part of a panel discussion titled, Public Private Partnerships to Accelerate Discoveries. The panel will be moderated by award-winning medical journalist Max Gomez, PhD., and will include David Mazzo, PhD CEO of Caladrius Biosciences, and David Pearce, PhD, the Executive VP for Research at Sanford Health.
The topic for this panel is particularly well suited for CIRM, an agency that is devoted to accelerating stem cell treatments to patients with unmet medical needs. CIRM has funded over 800 projects and over 45 novel stem cell and regenerative medicine clinical trials. It delivers a predictable and expedited funding mechanism, an active partnership and advisory role, strategic infrastructure, involvement of key opinion leaders and patient representatives and an industry alliance program, all to increase the chances of success for its programs and for the patients who would benefit.
To learn more about Unite To Cure: The Fourth International Vatican Conference, please visit: http://vaticanconference2018.com. Or, you can follow the event on Twitter @CuraFdn and on Facebook at
facebook.com/TheCuraFoundation, and join the conversation with #UnitetoCure.
| About CIRM |
| At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed in that mission.
To meet this challenge, our team of highly trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell technologies. With $3 billion in funding and approximately 300 active stem cell programs in our portfolio, CIRM is the world’s largest institution dedicated to helping people by bringing the future of cellular medicine closer to reality. For more information go to www.cirm.ca.gov The Cura Foundation leads a major global health movement, with the passionate purpose to improve human health. Cura unites public and private sectors, partnering with doctors, patients, business leaders, philanthropists and thought leaders to collaborate and create breakthroughs around the world. The foundation drives change by raising awareness of scientific advancements in genomics, emerging technologies and big data to usher in the future of medicine. Cura helps people live longer, better lives free from suffering. The Cura Foundation is a nonsectarian, nonpartisan, public and tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. For more information, please visit: https://thecurafoundation.org |
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
April 26, 2018, Oakland, CA – It’s not often you get invited to a meeting of some of the leading scientists, ethicists, philosophers and faith leaders in the world so when the call comes in it’s an easy one to answer. Particularly when the call is from the Vatican.
Maria T. Millan, MD, President and CEO of the California Institute for Regenerative Medicine (CIRM), will be part of a panel discussion at the Fourth International Vatican Conference at Vatican City, Rome. The conference, titled: Unite To Cure: How Science, Technology and 21st Century Medicine Will Impact Culture and Society, runs from April 26-28 in Rome.
“It is a tremendous honor to be part of this historic event,” says Dr. Millan. “CIRM funds the science and development of transformative cell and gene therapies for patients with unmet medical needs so it will be important to be part of the global conversation during such a propitious time in the history of medicine.”
“We’re thrilled to bring together the world’s best scientists, doctors, ethicists and leaders of faith, business, government and philanthropy to this extraordinary global event at The Vatican,” says Dr. Robin Smith, President of The Cura Foundation, the event organizer in partnership with the Vatican. “It’s a Davos for health care, and over the course of three days we will rally the world around a very simple idea — that tomorrow’s cures are just around the corner, and by uniting together and understanding the challenges that lie ahead, we can speed the delivery of cures and foster great hope for patients all over the world suffering from deadly diseases and dangerous medical conditions.”
Dr. Millan will be part of a panel discussion titled, Public Private Partnerships to Accelerate Discoveries. The panel will be moderated by award-winning medical journalist Max Gomez, PhD., and will include David Mazzo, PhD CEO of Caladrius Biosciences, and David Pearce, PhD, the Executive VP for Research at Sanford Health.
The topic for this panel is particularly well suited for CIRM, an agency that is devoted to accelerating stem cell treatments to patients with unmet medical needs. CIRM has funded over 800 projects and over 45 novel stem cell and regenerative medicine clinical trials. It delivers a predictable and expedited funding mechanism, an active partnership and advisory role, strategic infrastructure, involvement of key opinion leaders and patient representatives and an industry alliance program, all to increase the chances of success for its programs and for the patients who would benefit.
To learn more about Unite To Cure: The Fourth International Vatican Conference, please visit: http://vaticanconference2018.com. Or, you can follow the event on Twitter @CuraFdn and on Facebook at
facebook.com/TheCuraFoundation, and join the conversation with #UnitetoCure.
| About CIRM |
| At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed in that mission.
To meet this challenge, our team of highly trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell technologies. With $3 billion in funding and approximately 300 active stem cell programs in our portfolio, CIRM is the world’s largest institution dedicated to helping people by bringing the future of cellular medicine closer to reality. For more information go to www.cirm.ca.gov The Cura Foundation leads a major global health movement, with the passionate purpose to improve human health. Cura unites public and private sectors, partnering with doctors, patients, business leaders, philanthropists and thought leaders to collaborate and create breakthroughs around the world. The foundation drives change by raising awareness of scientific advancements in genomics, emerging technologies and big data to usher in the future of medicine. Cura helps people live longer, better lives free from suffering. The Cura Foundation is a nonsectarian, nonpartisan, public and tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. For more information, please visit: https://thecurafoundation.org |